Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diagnostics
    • BEWARE: Hepatitis C...

    BEWARE: Hepatitis C Infection most common in North India, points out SRL Diagnostics Study

    Written by Anjali Nimesh Nimesh Published On 2017-07-28T16:33:32+05:30  |  Updated On 28 July 2017 4:33 PM IST
    BEWARE: Hepatitis C Infection most common in North India, points out SRL Diagnostics Study

    New Delhi : An analysis done by SRL Diagnostics, the leading diagnostic chain in India on Viral Hepatitis (A, B, C, E) testing done in its laboratories revealed that Hepatitis C Virus infection was most common in the Northern states of India when compared with other parts of the country. However the water born Hepatitis E virus infection was found to be the most common laboratory diagnosed viral hepatitis in India, The data is based on the more than 8 lakh 11 thousand tests done pan India at SRL labs between January 2014 and May 2017.


    Hepatitis C virus (HCV), the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. However, 80-85% of individuals who contract HCV land up having a chronic hepatitis requiring extended, often lifelong, drug therapy. The hepatitis C virus is a blood-borne virus and the most common modes of infection are through exposure to small quantities of blood which may happen through injection drug use, unsafe injection practices, unsafe health care, and the transfusion of unscreened blood and blood products, or sexual contact with an infected person. Globally HCV prevalence is estimated at 1% with 71 million of HCV infected adults. A significant number of those who are chronically infected will develop cirrhosis or liver cancer. Approximately 399,000 people die each year from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma.


    The study also revealed that all four types of viral hepatitis are more common in young age groups of 16-30 and 31-45 years. The water borne virus infections, both HEV (Hepatitis E Virus) and HAV (Hepatitis A Virus) infections were particularly common in the young adult age group of 16-30 years while HCV (Hepatitis C Virus) infection was more common in middle age to elderly age groups of 46-60 and 61-85 years. HBV infection was observed to be evenly distributed across age groups.


    According to WHO - worldwide reports have recorded around 6-10 million newly infected cases. Based on the Global Health Sector Strategy on Viral Hepatitis report (2016-2021), viral hepatitis has been responsible for an estimated 1.4 million deaths per year from acute infection and hepatitis-related liver cancer and cirrhosis. The WHO report has stated that approximately 48% are attributable to hepatitis C virus, 47% to hepatitis B virus, and remaining to hepatitis A and hepatitis E viruses out of the 1.4 million deaths. Worldwide, approximately 257 million people have chronic hepatitis B virus infection.


    Commenting on the same, Dr. Avinash Phadke, President Technology & Mentor (Clinical Pathology) from SRL Diagnostics said, “Despite around 400 million people affected globally, hepatitis has largely been ignored as a health and development priority until recently. Four common types of viral hepatitis i.e. A, B, C, E have different modes of transmission, affecting different populations and resulting in different health outcomes. With time, there has been huge influx of people into urban areas of India and significant changes in lifestyle of the urban population. For HEV and HAV infections hygiene and sanitation practices play major roles, while for HBV and HCV, lifestyle and awareness are very important”

    CirrhosisdiagnosticDr Avinash PhadkeHAVHCVhepatitis A virusHepatitis C InfectionHepatitis C virusHepatocellular CarcinomaInfectionsliver cancerSRL DiagnosticsWHO

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok